Reduced serum somatomedin activity in patients with chronic liver disease.
D000328:Adult; D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D006528:Carcinoma, Hepatocellular / Q000097:blood; D002908:Chronic Disease; D005234:Fatty Liver / Q000097:blood; D005260:Female; D013006:Growth Hormone / Q000097:blood; D006801:Humans; D007501:Iron / Q000097:blood; D008103:Liver Cirrhosis / Q000097:blood; D008107:Liver Diseases / Q000097:blood*; D008113:Liver Neoplasms / Q000097:blood; D008297:Male; D008875:Middle Aged; D011485:Protein Binding; D011863:Radioimmunoassay; D012709:Serum Albumin / Q000032:analysis; D013002:Somatomedins / Q000097:blood*; D005723:gamma-Glutamyltransferase / Q000097:blood
D012709:Serum Albumin; D013002:Somatomedins; D013006:Growth Hormone; D007501:Iron; D005723:gamma-Glutamyltransferase; D001219:Aspartate Aminotransferases; D000469:Alkaline Phosphatase; D001663:Bilirubin